We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SVRA

Price
2.06
Stock movement down
-0.04 (-1.29%)
Company name
Savara Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
527.15M
Ent value
545.19M
Price/Sales
-
Price/Book
2.64
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-29.09%
1 year return
-31.46%
3 year return
22.73%
5 year return
10.28%
10 year return
-48.52%
Last updated: 2025-09-15

iO Charts is a Seeking Alpha partner

DIVIDENDS

SVRA does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book2.64
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count172.84M
EPS (TTM)-0.39
FCF per share (TTM)-0.38

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-202.00K
Operating income (TTM)-89.65M
Net income (TTM)-82.94M
EPS (TTM)-0.39
EPS (1y forward)-0.51

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash21.43M
Net receivables1.16M
Total current assets226.40M
Goodwill0.00
Intangible assets11.11M
Property, plant and equipment0.00
Total assets238.82M
Accounts payable4.61M
Short/Current long term debt26.71M
Total current liabilities12.79M
Total liabilities39.47M
Shareholder's equity199.35M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-81.41M
Capital expenditures (TTM)58.00K
Free cash flow (TTM)-81.47M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-41.60%
Return on Assets-34.73%
Return on Invested Capital-36.69%
Cash Return on Invested Capital-36.04%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.09
Daily high3.18
Daily low2.92
Daily Volume1.70M
All-time high970224.50
1y analyst estimate8.36
Beta0.40
EPS (TTM)-0.39
Dividend per share-
Ex-div date-
Next earnings date6 Nov 2025

Downside potential

Loading...
Downside potential data
SVRAS&P500
Current price drop from All-time high-100.00%-1.46%
Highest price drop-100.00%-56.47%
Date of highest drop28 Nov 20229 Mar 2009
Avg drop from high-90.77%-10.99%
Avg time to new high333 days12 days
Max time to new high6283 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
SVRA (Savara Inc) company logo
Marketcap
527.15M
Marketcap category
Small-cap
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Employees
59
Investor relations
-
SEC filings
CEO
Robert Norman Neville
Country
USA
City
Austin
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...